Find investors who align with your industry, stage, and vision. Unlock Martin Glen’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors todayMartin Glen is a Venture Capital, Investor based in Greater London, England, United Kingdom with a diverse investment portfolio that includes companies such as Nu Quantum, 1715Labs, Legislate Technologies, Porotech, YASA, Opsydia, Proxisense, Creavo Medical Technologies, Istesso, AudioTelligence, Quantum Motion Technologies, Duel, Bramble Energy, Entia, Nyobolt, DIOSynVax, Salunda, Cytoseek, Nozzle.ai, Ceryx Medical, Oxford Flow, Mind Foundry, MediaGamma, Silicon MicroGravity, Lumenisity, PolyProx, Oxford Endovascular, Arkivum, PhoreMost, Zentraxa, Symetrica, Oxbotica, GaitQ, Mirriad, PredictImmune, Undo, Kvasir Analytics, Ilika, GeoSpock, RoboK, Ikarovec, Qkine, NoBACZ, Cambridge GaN Devices, Inkpath, Psyomics, Echopoint Medical, Charco Neurotech, Inflowmatix, Cytora, Congenica, Fuel3D, Gripable, Perpetuum, Aqdot, PharmEnable, Phasecraft, Cambridge Touch Technologies Ltd., LettUs Grow, Mogrify, Inductosense, Xampla, PervasID, Echion Technologies, PetMedix, MoA Technology Ltd, Riverlane, Flusso, Paragraf, Carbometrics, Cambridge Photon Technology, Covatic, Sorex Sensors. Over time, Martin Glen has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Martin Glen is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Life Science, Artificial Intelligence (AI), Information Technology (IT), Biotech, Medical Device, Bioinformatics, Software, Diagnostics, Healthcare, Biotechnology, Computers, FinTech, UK-based Startups, Digital Health, Chemicals, Medical, Big Data, Therapeutics, Quantum Computing, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Martin Glen, as their portfolio suggests a familiarity and interest in this area.
Understanding Martin Glen’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today